CSIMarket


Protokinetix Incorporated  (PKTX)
Other Ticker:  
 

Protokinetix Incorporated

PKTX's Fundamental analysis








Protokinetix Incorporated's sales fell in IV. Quarter 2022 from the same quarter a year ago.

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -3.82 %



More on PKTX's Growth


Protokinetix Incorporated
reported net loss of -2 millions in the past twelve months.

Company
PE TTM   
Industry
0.01
PE TTM    
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.47.


More on PKTX's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $)

Protokinetix Incorporated
reported net loss of -2 millions in the past twelve months.

Company
PE TTM   
Industry
0.01
PE TTM    
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.47.